UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

FGF23 induces left ventricular hypertrophy

The Journal of clinical investigation, 2011-11, Vol.121 (11), p.4393-4408

2011

Volltextzugriff (PDF)

Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects

Nature communications, 2021-12, Vol.12 (1), p.7256-7256, Article 7256

2021

Volltextzugriff (PDF)

Randomized Placebo‐Controlled and Controlled Non‐Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects

Journal of bone and mineral research, 2016-04, Vol.31 (4), p.806-814

2016

Volltextzugriff (PDF)

Extracellular matrix-inspired growth factor delivery systems for bone regeneration

Advanced drug delivery reviews, 2015-11, Vol.94 (C), p.41-52

2015

Volltextzugriff (PDF)

NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis

Hepatology (Baltimore, Md.), 2020-04, Vol.71 (4), p.1198-1212

2020

Volltextzugriff (PDF)

Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2019-10, Vol.322 (14), p.1360

2019

Volltextzugriff (PDF)

Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase

Nature communications, 2020-02, Vol.11 (1), p.807-807, Article 807

2020

Volltextzugriff (PDF)

Once‐weekly administration of a long‐acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in obese people with hypertriglyceridaemia and in non‐human primates

Diabetes, obesity & metabolism, 2017-12, Vol.19 (12), p.1762-1772

2017

Volltextzugriff (PDF)

Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets

Gastroenterology (New York, N.Y. 1943), 2014-11, Vol.147 (5), p.1073-1083.e6

2014

Volltextzugriff (PDF)

FGF23 regulates renal sodium handling and blood pressure

EMBO molecular medicine, 2014-06, Vol.6 (6), p.744-759

2014

Volltextzugriff (PDF)

Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State

Diabetes (New York, N.Y.), 2010-11, Vol.59 (11), p.2781-2789

2010

Volltextzugriff (PDF)

FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1

American journal of physiology. Renal physiology, 2009-08, Vol.297 (2), p.F282-F291

2009

Volltextzugriff (PDF)

Intraarticular Sprifermin (Recombinant Human Fibroblast Growth Factor 18) in Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Arthritis & rheumatology (Hoboken, N.J.), 2014-07, Vol.66 (7), p.1820-1831

2014

Volltextzugriff (PDF)

The Hormone FGF21 Stimulates Water Drinking in Response to Ketogenic Diet and Alcohol

Cell metabolism, 2018-06, Vol.27 (6), p.1338-1347.e4

2018

Volltextzugriff (PDF)

Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ

Proceedings of the National Academy of Sciences - PNAS, 2012-02, Vol.109 (8), p.3143-3148

2012

Volltextzugriff (PDF)

LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest Hypertriglyceridemia

The journal of clinical endocrinology and metabolism, 2022-01, Vol.107 (1), p.e57-e70

2022

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of PF‐05231023, a novel long‐acting FGF21 mimetic, in a first‐in‐human study

British journal of clinical pharmacology, 2015-11, Vol.80 (5), p.1051-1063

2015

Volltextzugriff (PDF)

Fibroblast Growth Factor-21 Controls Dietary Protein Intake in Male Mice

Endocrinology (Philadelphia), 2019-05, Vol.160 (5), p.1069-1080

2019

Volltextzugriff (PDF)

FGF21 promotes metabolic homeostasis via white adipose and leptin in mice

PloS one, 2012-07, Vol.7 (7), p.e40164

2012

Volltextzugriff (PDF)

FGF21 requires βklotho to act in vivo

PloS one, 2012-11, Vol.7 (11), p.e49977

2012

Volltextzugriff (PDF)

Cellular Mechanisms by Which FGF21 Improves Insulin Sensitivity in Male Mice

Endocrinology (Philadelphia), 2013-09, Vol.154 (9), p.3099-3109

2013

Volltextzugriff (PDF)

Mussel-Inspired Surface Immobilization of Heparin on Magnetic Nanoparticles for Enhanced Wound Repair via Sustained Release of a Growth Factor and M2 Macrophage Polarization

ACS applied materials & interfaces, 2021-01, Vol.13 (2), p.2230-2244

2021

Volltextzugriff (PDF)

Lack of Overt FGF21 Resistance in Two Mouse Models of Obesity and Insulin Resistance

Endocrinology (Philadelphia), 2012-01, Vol.153 (1), p.69-80

2012

Volltextzugriff (PDF)

Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1

Biochimica et biophysica acta. Molecular basis of disease, 2019-06, Vol.1865 (6), p.1241-1252

2019

Volltextzugriff (PDF)

Differential regulation of renal Klotho and FGFR1 in normal and uremic rats

The FASEB journal, 2017-09, Vol.31 (9), p.3858-3867

2017

Volltextzugriff (PDF)

1 – 25 von 3.664

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.450)
Mit Volltextzugriff
(3.173)

Publikationsform

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.213)
Life Sciences & Biomedicine
(2.812)
Animals
(2.406)
Humans
(2.095)
Male
(1.571)
Female
(1.148)
Mice
(1.047)
Fibroblast Growth Factor 2 - Administration & Dosage
(871)
Biological And Medical Sciences
(830)
Fibroblasts
(767)
Rats
(755)
Growth Factors
(690)
Medical Sciences
(669)
Middle Aged
(517)
Cells, Cultured
(487)
Disease Models, Animal
(444)
Oncology
(439)
Adult
(433)
Dose-Response Relationship, Drug
(431)
Angiogenesis
(410)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(3.552)
Ingenta
(1.893)
EZB Electronic Journals Library
(1.862)
Journals@Ovid Ovid Full Text
(1.408)
IngentaConnect Journals
(842)
Elsevier ScienceDirect Journals Complete
(688)
Single Journals
(585)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(538)
Wiley Blackwell Single Titles
(496)
Wiley Online Library Full Collection 2018
(403)
Springer journals
(401)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(230)
Taylor & Francis Journals
(207)
Single Title from Nature Journals
(202)
Oxford Journals Online Current
(165)
Taylor & Francis
(159)
Taylor & Francis Online
(145)
Oxford Journals 2020 Medicine
(114)
Nexis Uni (LexisNexis)
(101)
SAGE Complete
(71)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(183)
Journal Of Controlled Release
(49)
Biomaterials
(43)
Scientific Reports
(43)
Biochemical And Biophysical Research Communications
(38)
International Journal Of Molecular Sciences
(35)
Gene Therapy
(31)
Clinical Cancer Research
(29)
Circulation
(24)
Cells
(21)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(17)

Menü

Weitere Dienste

Einstellungen

FGF23 induces left ventricular hypertrophy

Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects

Randomized Placebo‐Controlled and Controlled Non‐Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects

Extracellular matrix-inspired growth factor delivery systems for bone regeneration

NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis

Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial

Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase

Once‐weekly administration of a long‐acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in obese people with hypertriglyceridaemia and in non‐human primates

Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets

FGF23 regulates renal sodium handling and blood pressure

Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State

FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1

Intraarticular Sprifermin (Recombinant Human Fibroblast Growth Factor 18) in Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial

The Hormone FGF21 Stimulates Water Drinking in Response to Ketogenic Diet and Alcohol

Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ

LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest Hypertriglyceridemia

Pharmacokinetics and pharmacodynamics of PF‐05231023, a novel long‐acting FGF21 mimetic, in a first‐in‐human study

Fibroblast Growth Factor-21 Controls Dietary Protein Intake in Male Mice

FGF21 promotes metabolic homeostasis via white adipose and leptin in mice

FGF21 requires βklotho to act in vivo

Cellular Mechanisms by Which FGF21 Improves Insulin Sensitivity in Male Mice

Mussel-Inspired Surface Immobilization of Heparin on Magnetic Nanoparticles for Enhanced Wound Repair via Sustained Release of a Growth Factor and M2 Macrophage Polarization

Lack of Overt FGF21 Resistance in Two Mouse Models of Obesity and Insulin Resistance

Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1

Differential regulation of renal Klotho and FGFR1 in normal and uremic rats

Suchergebnisse filtern